Bayer | BAYN - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Air Liquide EUR 26.52B 303.1M 2026-06
Akzo Nobel EUR 4.85B 28M 2026-06
Alcon AG USD 21.6B 538M 2026-06
Amarin USD 443.62M 5.8M 2026-06
Arkema EUR 6.78B 176.8M 2026-06
AstraZeneca USD 50.3B 2.96B 2026-06
BASF EUR 36.32B 846M 2026-06
Bayer EUR 29.71B 863M 2026-06
Beiersdorf EUR 8.6B 133M 2025-12
Corteva USD 25.16B 797M 2026-06
Covestro EUR 7B 908M 2025-12
Essilor EUR 39.22B 329M 2026-06
Fresenius EUR 19.7B 766M 2026-06
Fresenius Medical Care EUR 13.53B 673.44M 2026-06
Genmab DKK 5.96B 275M 2026-06
Givaudan CHF 4.54B 430M 2025-12
GlaxoSmithKline GBP 17.64B 223M 2026-06
GRIFOLS EUR 7.98B 2.52B 2026-06
Henkel EUR 20.97B 479M 2026-06
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Johnson Matthey GBP 2.02B 85M 2026-06
Linde USD 40.09B 1.85B 2026-03
Lonza CHF 9.13B 513M 2025-12
Merck EUR 30.17B 430M 2026-06
Novartis USD 41.95B 3.02B 2026-06
Nutrien USD 25.9B 748M 2026-06
Philips EUR 11.48B 84M 2026-06
PPG Industries USD 8.59B 486M 2026-06
Roche Holding CHF 32.69B 1.11B 2026-06
Sanofi EUR 69.57B 3.24B 2026-06
SAP EUR 44.74B 117M 2026-06
Solvay EUR 1.11B 70M 2026-06
UCB EUR 10.87B 1.18B 2025-12
Umicore EUR 2.66B 424.8M 2026-06
Vinci EUR 30.59B 3.74B 2026-06